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Abstract
Background:  Ectopic chondrogenesis and ossification were observed in a degenerative
collagenase-induced calcific tendinopathy model and to a lesser extent, in a patellar tendon
traumatic injury model. We hypothesized that expression of bone morphogenetic protein-2 (BMP-
2) contributed to ectopic chondrogenesis and ossification. This study aimed to study the spatial and
temporal expression of BMP-2 in our animal models.
Methods: Seventy-two rats were used, with 36 rats each subjected to central one-third patellar
tendon window injury (C1/3 group) and collagenase-induced tendon injury (CI group), respectively.
The contralateral limb served as controls. At week 2, 4 and 12, 12 rats in each group were
sacrificed for immunohistochemistry and RT-PCR of BMP-2.
Results: For CI group, weak signal was observed at the tendon matrix at week 2. At week 4,
matrix around chondrocyte-like cells was also stained in some samples. In one sample, calcification
was observed and the BMP-2 signal was observed both in the calcific matrix and the embedded
chondrocyte-like cells. At week 12, the staining was observed mainly in the calcific matrix. Similar
result was observed in C1/3 group though the immunopositive staining of BMP-2 was generally
weaker. There was significant increase in BMP-2 mRNA compared to that in the contralateral side
at week 2 and the level became insignificantly different at week 12 in CI group. No significant
increase in BMP-2 mRNA was observed in C1/3 group at all time points.
Conclusion: Ectopic expression of BMP-2 might induce tissue transformation into ectopic bone/
cartilage and promoted structural degeneration in calcific tendinopathy.
Background
Calcific tendinopathy is a poorly characterized tendon
degenerative disorder that is extremely common in ath-
letes as well as in the general population with repetitive
tendon overuse. Despite its prevalence, its underlying
pathogenesis is poorly understood and treatment is usu-
ally symptomatic. Recently, we reported the presence of
chondrocyte phenotype and ectopic ossification in a col-
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lagenase-induced patellar tendon injury model [1]. Erro-
neous differentiation of healing tendon fibroblasts might
account for failed healing and ossification in the model
[1]. A lower chance and extent of ectopic chondrogenesis
and ossification were observed after traumatic patellar
tendon traumatic injury which healed with reduced cellu-
larity, vascularity and reorganization of extracellular
matrix. (Lui PPY, Cheuk YC, Fu SC, Chan KM: Chon-
drometaplasia and Ossification During Repair of Patella
Tendon Injury, submitted) This suggested similar biolog-
ical pathway might be activated in both traumatic and col-
lagenase-induced tendon injuries. The extent of injury
might determine the healed or fail-healing status, consist-
ent with failed healing in tendinopathy was due to the
accumulation of micro-injuries that the tendon failed to
resolve.
Bone morphogenetic proteins are multi-functional
growth factors that belong to the TGF-beta superfamily
[2]. They have strong effect on bone and cartilage growth
as well as with important roles during embryonic pattern
and early skeletal formation. To date, around 20 BMP
family members have been identified. BMP-2 is among
the most studied member of the family and has been used
in many studies for augmentation of bone and bone-ten-
don junction regeneration [3,4]. Because of the role of
BMP-2 in bone formation, it is commonly found in bone
and is generally absent in tendon. We hypothesized that
ectopic expression of BMP-2 contributed to ectopic chon-
drogenesis and ossification in our animal models. This
study aimed to report the spatial and temporal expression
of BMP-2 protein and mRNA in both animal models.
Methods
This study was approved by the Animal Research Ethics
Committee of the authors' institution.
Traumatic tendon injury model
Thirty-six Sprague-Dawley male adult rats (6–8 weeks,
average body weight of 300 g) were used [5]. Under gen-
eral anesthesia, an incision was made to expose the patel-
lar tendon. The central one-third of the patellar tendon (1
× 4 mm) from the distal apex of the patellar to the inser-
tion of the tibial tuberosity was then removed and the gap
was left open. The wound was then closed in layers. Sham
operation was performed in the contralateral limb and
served as control.
Collagenase-induced injury
Thirty-six male Sprague Dawley rats, (8 weeks, weight
200–250 grams) were used [1]. After anesthesia with 2.5%
pentobarbital (4.5 mg/kg body weight), hairs over the
lower limb were shaved. Patellar tendon was located by
positioning the knee at 90°. Twenty microliters (0.015
mg/μl in 0.9% saline, i.e. 0.3 mg) of bacterial collagenase
I (Sigma-Aldrich, St Louis, MO) or saline were injected
into the patellar tendon intratendinously with a 30G nee-
dle in one limb while the contralateral limb was injected
with saline [6].
Sample harvest
The rats with different surgical procedures were allowed
free cage movement immediately after surgery. At week 2,
4 and 12 after injury, the rats were sacrificed and the patel-
lar tendons in both limbs were harvested (n = 12). Six
samples were used for immunohistochemical staining of
BMP-2 and the other six samples were used for real time
RT-PCR.
General histology and immunohistochemistry
The patellar tendon was washed in PBS, fixed in buffered
formalin and 100% ethanol, embedded in paraffin, cut
longitudinally to 5-μm thick sections and mounted on 3-
aminopropyl-triethoxy-silane (Sigma-Aldrich, St Louis,
MO) coated slides. After deparaffination, the sections
were stained with haematoxylin and eosin. Immunohisto-
chemistry was done as described previously [1,5]. Briefly,
after removal of paraffin, the sections were rehydrated,
decalcified, quenched of endogenous peroxidase activity
and subjected to antigen retrieval. After blocking with 5%
normal donkey serum, the sections were stained with spe-
cific antibodies against BMP-2 (Santa Cruz Biotechnol-
ogy, Santa Cruz, CA; 1:100) at 4°C overnight. Donkey
anti-goat horseradish peroxidase (HRP)-conjugated sec-
ondary antibody (Santa Cruz Biotechnology; 1:100) was
then added for an hour, followed by 3,3' diaminobenzi-
dine tetrahydrochloride (DAKO, Glostrup, Denmark) in
the presence of H2O2. Afterwards, the sections were
rinsed, counterstained in hematoxylin, dehydrated with
graded ethanol and xylene, and mounted with p-xylene-
bis-pyridinium bromide (DPX) permount (Sigma
Aldrich, St Louis, MO). Primary antibody was replaced
with blocking solution in the controls. For good reproduc-
ibility and comparability, all incubation times and condi-
tions were strictly controlled. The sections were examined
under light microscopy (Leica DMRXA2, Leica Microsys-
tems Wetzlar GmbH, Germany).
Quantitative real-time RT-PCR
The patellar tendon was harvested and homogenized for
RNA extraction with Trizol reagent (Gibco BRL, Life Tech-
nologies, Invitrogen, Carlsbad, CA). The RNA was reverse
transcribed to cDNA by the First Strand cDNA kit
(Promega, Madison, WI). The primer sequences and
annealing temperature for BMP-2 and -actin were shown
in Table 1. The real-time PCR machine, the reaction kits,
and the software used in the experiments were purchased
from Roche (LightCycler, Roche Diagnostics GmbH, Pen-
zbergh, Germany). The expression of BMP-2 was normal-
ized to the expression of β-actin gene. Relative geneJournal of Orthopaedic Surgery and Research 2009, 4:27 http://www.josr-online.com/content/4/1/27
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expression of the operated limb to the control limb was
calculated according to the 2-ΔΔCT formula.
Data analysis
The immunohistochemical data was qualitatively
described. The mRNA data was presented in box-plots. To
compare the mRNA level among different time points,
Kruskal-Wallis test followed by post-hoc comparison of
different time points with control using Mann-Whitney U
test was performed. To compare the mRNA level of injury
groups with the time-matched controls, Wilcoxon signed-
rank test was used. All the data analysis was done using
SPSS (SPSS Inc, Chicago, IL, version 16.0). p < 0.05 was
regarded as statistically significant.
Results
Immunohistochemistry of BMP-2
No immunopositivity of BMP-2 was observed in both
control groups (Figure 1A and 1F). For the collagenase-
induced calcific tendinopathy model, weak signal was
observed at the tendon matrix at week 2 (Figure 1B,
arrows). At week 4, tendon matrix was still stained (Figure
1C, arrows) and matrix around chondrocyte-like cells was
also stained (Figure 1C, arrowheads), consistent with the
time of appearance of chondrocyte-like cells in this ani-
mal model. In one sample, calcification was observed and
BMP-2 signal was observed both in the chondrocyte-like
cells embedded in calcific matrix and the surrounding
matrix. At week 12, the staining was observed mainly in
chondrocyte-like cells within the calcific matrix in all sam-
ples (Figure 1D, CR) and chondrocyte-like cells in uncal-
cific matrix (Figure 1E, arrowheads).
Similar result was observed in the central one-third trau-
matic injury model though the immunopositive staining
of BMP-2 was generally weaker. At weeks 2 and 4, weak
signal was observed in the tendon cell matrix in 6/6 sam-
ples (Figure 1B, arrows) and 5/6 samples, (Figure 1B,
arrows) respectively. The signal at week 4 was stronger
than that at week 2. At week 12, the matrix around the
chondrocyte-like cells was stained in 3/3 samples (Figure
1J, arrowheads). The calcific matrix and the embedded
chondrocyte-like cells (Figure 1I, arrowheads) were
stained in samples with calcific deposits. The overall
immunopositive staining of BMP-2 decreased at week 12.
mRNA expression of BMP-2
For the collagenase-induced calcific tendinopathy group,
there was significant increase in mRNA expression of
BMP-2 compared to that at the contralateral side at week
2 (p = 0.046) (Figure 2A). There was also increase in
mRNA expression of BMP-2 at week 4 but it was margin-
ally insignificant (p = 0.068). The mRNA level became
insignificantly different from that at the contralateral side
at week 12 (p = 0.225). There was significant difference in
mRNA level of BMP-2 between week 2 and week 4 with
week 12 (overall: p = 0.021; post-hoc comparison: week 2
vs week 12: p = 0.016; week 4 vs week 12: p = 0.022).
For the central one-third traumatic injury group, there was
no significant difference in BMP-2 mRNA expression
compared to that at the contralateral side despite the
increase at week 2 and week 4 (all p > 0.05) (Figure 2B).
Discussion
The pathogenesis of calcific tendinopathy, including the
cause of tendon pain, tendon degeneration and calcifica-
tion, remained largely unknown and hence current treat-
ments are usually symptomatic. Change of tendon
loading due to mechanical overload, compression or dis-
use have been implicated as the possible etiologies [7],
but they do not completely explain the cellular and
molecular alternations seen in the diseased tendon such
as chondrometaplasia and ectopic ossification, hypercel-
lularity, vascularity and extracellular matrix degeneration.
Ectotopic chondrogenesis and ossification have been
reported in our established patellar calcific tendinopathy
rat model and to a lesser extent, in the traumatic patellar
tendon injury model [1]. (Lui Cheuk YC, Fu SC, Chan KM:
Chondrometaplasia and Ossification During Repair of
Patella Tendon Injury, submitted) We hypothesized that
ectopic expression of BMP-2 might be involved in the
chondrometaplasia and ossification in both models. This
study aimed to study the spatial and temporal expression
of BMP-2 protein and mRNA in both animal models.
BMP-2 protein was detected in the chondrocyte-like cells
and calcific deposits in both injury models but not in con-
trol samples, indicating that BMP-2 might be involved in
the pathogenesis of ectopic chondrogenesis and ossifica-
tion. There was also increase in BMP-2 mRNA at week 2
Table 1: Table showing the primer sequences and annealing temperature of target genes
Gene Primer sequences Annealing temperature
BMP-2 Forward: 5'-TAGTGACTTTTGGCCACGACG-3' 58°C
Reverse: 5'-GCTTCCGCTGTTTGTGTTTG-3'
β-actin Forward: 5'-ATCGTGGGCCGCCCTAGGCA-3' 52°C
Reverse: 5' TGGCCTTAGGGTTCAGAGGGG-3'Journal of Orthopaedic Surgery and Research 2009, 4:27 http://www.josr-online.com/content/4/1/27
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and week 4 in both injury models though it was statisti-
cally significant only at week 2 for the collagenase-
induced calcific tendinopathy group. This was consistent
with previous clinical study which reported ectopic over-
expression of BMPs in the subacromial bursa and it was
suggested to account for the chondrogenic transformation
and ectopic mineralization of rotator cuff tendon in
patients [8]. The expression of BMP-2 in the chondrocyte-
like cells and calcific deposits suggested that BMP-2 might
be involved in ectopic chondrogenesis and ossification.
This was supported by the reported role of BMP-2 in pro-
moting chondrocyte differentiation, osteoblast differenti-
ation and endochondral ossification [9,10]. The
insignificant difference in mRNA expression in both mod-
els might be due to the large sample variation, particularly
for the traumatic injury group which showed only 50%
calcification rate and at a much lower extent, and the
expression became more focal, localizing mainly at the
chondrocyte-like cells and calcific deposits, at week 12 in
both models. As the mRNA expression was calculated
based on total cells, this might dilute the expression at
week 12. Care therefore should be taken when interpret-
ing the mRNA data and studying the expression also at the
protein level by immunohistochemistry is suggested in
tissue samples.
As we observed earlier expression of BMP-2 mRNA and
protein at week 2 in healing tendon cells, before the time
of its appearance in chondrocyte-like cells and calcific
deposits, this also supported that calcific tendon degener-
ation is mediated by the healing tendon cells which have
plasticity and are under erroneous cell differentiation due
to the changes in the mechanical and biological microen-
vironment. Indeed, injection of rhBMP-2 into tendon
increased ectopic bone formation, indicating that tendon
consisted of cells that were responsive to BMP-2 and were
capable of differentiating along the chondro-osseous
pathway [11]. Another study also reported that BMP
could induce transdifferentiation of tenocytes into
chondrocytes in vitro [12]. Arthritic synovial membranes
have also been shown to express BMP-2 & BMP-6 and
could influence cell turnover [13].
We observed lower level of expression of BMP-2 at similar
chondrogenic and ossification sites in the traumatic ten-
don injury model. This agreed with the lower degree and
extent of ectopic chondrogenesis and ossification in the
model and further supported the role of BMP-2 in ectopic
chondrogenesis and ossification.
Regarding the possible changes in mechanical and biolog-
ical microenvironment that cause the ectopic expression
of BMP-2 in tendons, it is currently not clear. Small leu-
cine-rich repeat proteoglycans such as biglycan and fibro-
modulin were reported to regulate the differentiation of
tendon progenitor cells into chondrocytes and bone cells
through modulating the BMP-2 signaling pathway [14].
In their study, tendon progenitor cells from biglycan- and
fibromodulin- knockout mice formed bone in addition to
Immunohistochemical staining of BMP-2 in collagenase- induced calcific tendinopathy and central one-third traumatic  injury model Figure 1
Immunohistochemical staining of BMP-2 in colla-
genase-induced calcific tendinopathy and central 
one-third traumatic injury model. (A-E) collagenase-
induced calcific tendinopathy and (F-I) central one-third 
patellar tendon traumatic injury models at different time 
points. A: week 12 saline-injection control; B: week 2; C: 
week 4; D-E: week 12 after collagenase injection. F: week 12 
sham control; G: week 2; H: week 4; I-J: week 12 after cen-
tral one-third traumatized injury. For the collagenase-
induced calcific tendinopathy group, weak signal was 
observed at the tendon matrix at week 2. At week 4, matrix 
around chondrocyte-like cells was also stained. At week 12, 
the staining was observed mainly in the calcific matrix and the 
matrix around chondrocyte-like cells. Similar result was 
observed in the central one-third patellar tendon traumatic 
injury group though the immunopositive staining of BMP-2 
was generally weaker. At weeks 2 and 4, weak signal was 
observed in the tendon cell matrix. At week 12, the matrix 
around chondrocyte-like cells and the calcific matrix were 
stained. No immunopositivity of BMP-2 was observed in both 
control groups. arrows: tendon cells; arrowheads: chondro-
cyte-like cells; CR: calcific region; Magnification: 400×; error 
bar: 100 μmJournal of Orthopaedic Surgery and Research 2009, 4:27 http://www.josr-online.com/content/4/1/27
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tendon-like tissue after transplantation in vivo, whereas
wild type tendon progenitor cells only formed tendon-
like tissue [14]. There was increased sensitivity of tendon
progenitor cells from biglycan- and fibromodulin- knock-
out mice to BMP-2 stimulation with increased phosphor-
ylation of Smad1, Smad5 and Smad8 as well as more
abundant nuclear localization of phosphorylated Smad1
than those of wild type cells [12]. Changes in the compo-
sition of the extracellular matrix might affect the cellular
response of healing tendon cells and promote their differ-
entiation to osteoblasts and chondroblasts rather than
tenoblasts.
In addition to BMP-2, other members of the TGF-beta
superfamily such as BMP-4, BMP-7 and TGF-beta 1, may
also induce tissue transformation into ectopic bone/carti-
lage and promoted structural degeneration in calcific
tendinopathy. Previous studies have shown that BMP-4
was involved in cutaneous [15] and muscle ossification
[16]. BMP-4 and -7 and TGF-beta1 were also reported to
be involved in the initiation and development of ossifica-
tion of spinal ligaments (OSL) [17]. Activities of BMPs are
inhibited extracellularly by BMP-binding proteins such as
Noggin and Chordin as well as intracellularly by Smad6,
tob and Smurf1 [2]. Information on the expression of
these osteogenic factors and BMP antagonists, in addition
to the expression of BMP-2, will give a more comprehen-
sive picture of the osteogenic signals contributing to the
regulation of ectopic chondrogenesis and ossification in
calcific tendinopathy.
Conclusion
In conclusion, we reported the expression of BMP-2 in
tendon cells, chondrocyte-like cells and calcific deposits
in the calcific tendinopathy animal model, and to a lesser
extent, in the traumatic window injury model, which
might account for the chondrometaplasia and ectopic
ossification. Further studies are required to understand
the causes for increased expression of BMP-2 and the role
of BMP-2 signaling pathway in tendon cell differentiation
and tendon degeneration.
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